10,183 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Brooktree Capital Management

Brooktree Capital Management bought a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 10,183 shares of the medical device company’s stock, valued at approximately $683,000. DexCom makes up 0.6% of Brooktree […]

Leave a Reply

Your email address will not be published.

Previous post Dyne Therapeutics (NASDAQ:DYN) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS
Next post Actelis Networks Reports Strong Financial Results for Q3 2024